CUSIP: 25456J104
Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,136,705
-
Share change
-
+203,096
-
Total reported value
-
$43,913,000
-
Price per share
-
$14.00
-
Number of holders
-
28
-
Value change
-
+$2,931,023
-
Number of buys
-
18
-
Number of sells
-
13
Quarterly Holders Quick Answers
What is CUSIP 25456J104?
CUSIP 25456J104 identifies DPRX - DIPEXIUM PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2015
-
Previous quarter:
Q2 2015
Recent filing periods for CUSIP 25456J104:
Institutional Holders of DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) as of Q3 2015
As of 30 Sep 2015,
DIPEXIUM PHARMACEUTICALS INC - COM (DPRX) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,136,705 shares.
The largest 10 holders included
KINGDON CAPITAL MANAGEMENT, L.L.C., Tourbillon Capital Partners, L.P., Broadfin Capital, LLC, Timpani Capital Management LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, Lone Star Value Management LLC, RUSSELL FRANK CO/, 683 Capital Management, LLC, and ARDSLEY ADVISORY PARTNERS.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.